FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914647410> ?p ?o ?g. }

• W2914647410 endingPage "411.e3" @default.
• W2914647410 startingPage "403" @default.
• W2914647410 abstract "Objective Trigeminal nerve stimulation (TNS), a minimal-risk noninvasive neuromodulation method, showed potential benefits for attention-deficit/hyperactivity disorder (ADHD) in an unblinded open study. The present blinded sham-controlled trial was conducted to assess the efficacy and safety of TNS for ADHD and potential changes in brain spectral power using resting-state quantitative electroencephalography. Method Sixty-two children 8 to 12 years old, with full-scale IQ of at least 85 and Schedule for Affective Disorders and Schizophrenia–diagnosed ADHD, were randomized to 4 weeks of nightly treatment with active or sham TNS, followed by 1 week without intervention. Assessments included weekly clinician-administered ADHD Rating Scales (ADHD-RS) and Clinical Global Impression (CGI) scales and quantitative electroencephalography at baseline and week 4. Results ADHD-RS total scores showed significant group-by-time interactions (F1,228 = 8.12, p = .005; week 4 Cohen d = 0.5). CGI-Improvement scores also favored active treatment (χ21,168 = 8.75, p = .003; number needed to treat = 3). Resting-state quantitative electroencephalography showed increased spectral power in the right frontal and frontal midline frequency bands with active TNS. Neither group had clinically meaningful adverse events. Conclusion This study demonstrates TNS efficacy for ADHD in a blinded sham-controlled trial, with estimated treatment effect size similar to non-stimulants. TNS is well tolerated and has minimal risk. Additional research should examine treatment response durability and potential impact on brain development with sustained use. Clinical trial registration information Trigeminal Nerve Stimulation for ADHD; http://clinicaltrials.gov/; NCT02155608. Trigeminal nerve stimulation (TNS), a minimal-risk noninvasive neuromodulation method, showed potential benefits for attention-deficit/hyperactivity disorder (ADHD) in an unblinded open study. The present blinded sham-controlled trial was conducted to assess the efficacy and safety of TNS for ADHD and potential changes in brain spectral power using resting-state quantitative electroencephalography. Sixty-two children 8 to 12 years old, with full-scale IQ of at least 85 and Schedule for Affective Disorders and Schizophrenia–diagnosed ADHD, were randomized to 4 weeks of nightly treatment with active or sham TNS, followed by 1 week without intervention. Assessments included weekly clinician-administered ADHD Rating Scales (ADHD-RS) and Clinical Global Impression (CGI) scales and quantitative electroencephalography at baseline and week 4. ADHD-RS total scores showed significant group-by-time interactions (F1,228 = 8.12, p = .005; week 4 Cohen d = 0.5). CGI-Improvement scores also favored active treatment (χ21,168 = 8.75, p = .003; number needed to treat = 3). Resting-state quantitative electroencephalography showed increased spectral power in the right frontal and frontal midline frequency bands with active TNS. Neither group had clinically meaningful adverse events. This study demonstrates TNS efficacy for ADHD in a blinded sham-controlled trial, with estimated treatment effect size similar to non-stimulants. TNS is well tolerated and has minimal risk. Additional research should examine treatment response durability and potential impact on brain development with sustained use." @default.
• W2914647410 created "2019-02-21" @default.
• W2914647410 creator A5004540840 @default.
• W2914647410 creator A5033059527 @default.
• W2914647410 creator A5040841647 @default.
• W2914647410 creator A5041808631 @default.
• W2914647410 creator A5046157340 @default.
• W2914647410 creator A5052303749 @default.
• W2914647410 creator A5061813899 @default.
• W2914647410 creator A5064876957 @default.
• W2914647410 creator A5083430244 @default.
• W2914647410 date "2019-04-01" @default.
• W2914647410 modified "2023-10-02" @default.
• W2914647410 title "Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder" @default.
• W2914647410 cites W125676077 @default.
• W2914647410 cites W1493163011 @default.
• W2914647410 cites W1506520709 @default.
• W2914647410 cites W1719007579 @default.
• W2914647410 cites W1967686787 @default.
• W2914647410 cites W1983302342 @default.
• W2914647410 cites W1988048905 @default.
• W2914647410 cites W1988821796 @default.
• W2914647410 cites W1989145429 @default.
• W2914647410 cites W2017152382 @default.
• W2914647410 cites W2036725966 @default.
• W2914647410 cites W2043358844 @default.
• W2914647410 cites W2059171296 @default.
• W2914647410 cites W2061266457 @default.
• W2914647410 cites W2074134542 @default.
• W2914647410 cites W2095491799 @default.
• W2914647410 cites W2121049815 @default.
• W2914647410 cites W2126282700 @default.
• W2914647410 cites W2128495200 @default.
• W2914647410 cites W2131099228 @default.
• W2914647410 cites W2146721597 @default.
• W2914647410 cites W2148083007 @default.
• W2914647410 cites W2152322012 @default.
• W2914647410 cites W2156821941 @default.
• W2914647410 cites W2167095726 @default.
• W2914647410 cites W2213277078 @default.
• W2914647410 cites W2272053455 @default.
• W2914647410 cites W2321904998 @default.
• W2914647410 cites W2407531858 @default.
• W2914647410 cites W2573855591 @default.
• W2914647410 cites W2743144033 @default.
• W2914647410 cites W2751755304 @default.
• W2914647410 cites W2756217964 @default.
• W2914647410 cites W2767901467 @default.
• W2914647410 doi "https://doi.org/10.1016/j.jaac.2018.11.013" @default.
• W2914647410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6481187" @default.
• W2914647410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30768393" @default.
• W2914647410 hasPublicationYear "2019" @default.
• W2914647410 type Work @default.
• W2914647410 sameAs 2914647410 @default.
• W2914647410 citedByCount "58" @default.
• W2914647410 countsByYear W29146474102019 @default.
• W2914647410 countsByYear W29146474102020 @default.
• W2914647410 countsByYear W29146474102021 @default.
• W2914647410 countsByYear W29146474102022 @default.
• W2914647410 countsByYear W29146474102023 @default.
• W2914647410 crossrefType "journal-article" @default.
• W2914647410 hasAuthorship W2914647410A5004540840 @default.
• W2914647410 hasAuthorship W2914647410A5033059527 @default.
• W2914647410 hasAuthorship W2914647410A5040841647 @default.
• W2914647410 hasAuthorship W2914647410A5041808631 @default.
• W2914647410 hasAuthorship W2914647410A5046157340 @default.
• W2914647410 hasAuthorship W2914647410A5052303749 @default.
• W2914647410 hasAuthorship W2914647410A5061813899 @default.
• W2914647410 hasAuthorship W2914647410A5064876957 @default.
• W2914647410 hasAuthorship W2914647410A5083430244 @default.
• W2914647410 hasBestOaLocation W29146474102 @default.
• W2914647410 hasConcept C118552586 @default.
• W2914647410 hasConcept C126322002 @default.
• W2914647410 hasConcept C138496976 @default.
• W2914647410 hasConcept C142724271 @default.
• W2914647410 hasConcept C15744967 @default.
• W2914647410 hasConcept C168563851 @default.
• W2914647410 hasConcept C197934379 @default.
• W2914647410 hasConcept C204787440 @default.
• W2914647410 hasConcept C24998067 @default.
• W2914647410 hasConcept C27081682 @default.
• W2914647410 hasConcept C2776000289 @default.
• W2914647410 hasConcept C2777397368 @default.
• W2914647410 hasConcept C2780087125 @default.
• W2914647410 hasConcept C2780375056 @default.
• W2914647410 hasConcept C2780783007 @default.
• W2914647410 hasConcept C2781404750 @default.
• W2914647410 hasConcept C2985799443 @default.
• W2914647410 hasConcept C42219234 @default.
• W2914647410 hasConcept C522805319 @default.
• W2914647410 hasConcept C548259974 @default.
• W2914647410 hasConcept C71924100 @default.
• W2914647410 hasConcept C83849319 @default.
• W2914647410 hasConceptScore W2914647410C118552586 @default.
• W2914647410 hasConceptScore W2914647410C126322002 @default.
• W2914647410 hasConceptScore W2914647410C138496976 @default.
• W2914647410 hasConceptScore W2914647410C142724271 @default.
• W2914647410 hasConceptScore W2914647410C15744967 @default.

• next